« Previous
Next »
PAIN
Volume 147, Issue 1
, Pages 9-10
, 15 December 2009
Etifoxine (Stresam®) for chemotherapy-induced pain?
References
- . Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3α-reduced neurosteroids. Pain. 2009;147:54–59
- . Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol. 2006;72:151–169
- . Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature. 2003;424:938–942
- . Etifoxine improves peripheral nerve regeneration and functional recovery. Proc Natl Acad Sci USA. 2008;105:20505–20510
- . The modulatory effects of the anxiolytic etifoxine on GABAa receptors are mediated by the beta subunit. Neuropharmacology. 2003;45:293–303
- . Cancer pain epidemiology: a systematic review. In: Bruera ED, Portenoy RK editor. Cancer pain-assenssment and management. Cambridge: Cambridge University Press; 2003;p. 19–37
- . Reversal of pathological pain through specific spinal GABAa receptor subtypes. Nature. 2008;451:330–334
- . Translocator protein (18
kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402–409 - . Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine. Neuropharmacology. 2000;39:1523–1535
PII: S0304-3959(09)00557-0
doi: 10.1016/j.pain.2009.09.021
© 2009 International Association for the Study of Pain. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
PAIN
Volume 147, Issue 1
, Pages 9-10
, 15 December 2009

